EGF and breast carcinoma: In breast cancer cells, endogenous levels of Rac1, PI3K and PAK1 were all stimulated following treatment with epidermal growth factor (EGF) leading to increased migration[127], however in cells expressing a PAK1 kinase dead mutant this migratory response to EGF was significantly diminished.